N-substituted butyramide derivatives useful for treatment of con

Details N-substituted butyramide derivatives useful for treatment of con N-substituted butyramide derivatives useful for treatment of con

1987-09-17

1990-07-03

Rotman, Alan L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514332, 514510, 514533, 514563, 546265, 546337, 560 39, 560 41, 562450, 562444, C07D21355, C07C10102, C07C10314, A61K 3144

Patent

active

049392611

ABSTRACT:
Disclosed are compounds of the formula ##STR1## wherein X and Y independently represent hydroxymethyl; cyano; carboxy; functionally modified carboxy selected from esterified carboxy, carbamoyl, and N-substituted carbamoyl; 5-tetrazolyl; 2-oxazolyl, 4,5-dihydro-2-oxazolyl, 2-imidazolyl or 4,5-dihydro-2-imidazolyl or any said grouping substituted by lower alkyl; R and R.sub.0 independently represent hydrogen, lower alkyl, (C.sub.3 -C.sub.7)-cycloalkyl-lower alkyl, or aryl-lower alkyl in which aryl represents phenyl, pyridyl, thienyl, furyl, biphenyl or naphthyl, each unsubstituted or mono- or di-substituted by halogen, lower alkyl, hydroxy, acyloxy, lower alkoxy, trifluoromethyl or cyano; A represents straight chain (C.sub.2 -C.sub.5)-alkylene; or A represents straight chain (C.sub.2 -C.sub.5)-alkylene substituted by lower alkyl, by lower alkylthio-lower alkyl, by hydroxy-lower alkyl, by acyloxy-lower alkyl, by lower alkoxy-lower alkyl, by amino or acyl-amino, by amino-lower alkyl, by acylamino-lower alkyl, by (C.sub.3 -C.sub.7)-cycloalkyl, by (C.sub.3 -C.sub.7)-cycloalkyl-lower alkyl, by aryl or aryl-lower alkyl in which aryl represents phenyl or phenyl mono- or disubstituted by halogen, lower alkyl, lower alkoxy, hydroxy, acyloxy, trifluoromethyl or cyano; or A represents phenylene or cyclohexylene; pharmaceutically acceptable prodrug derivatives of any said compounds having a free carboxy group; pharmaceutically acceptable salts of any said compounds with a salt-forming group; methods for synthesis; pharmaceutical compositions thereof; and use thereof as enkephalinase inhibitors.

REFERENCES:
patent: 4052511 (1977-10-01), Cushman et al.
patent: 4105789 (1978-08-01), Ondetti et al.
patent: 4311705 (1982-01-01), Ondetti et al.
patent: 4374847 (1983-01-01), Gruenfeld
patent: 4610816 (1986-09-01), Berger
Lecouite et al, J. Pharmacology Expermental Therapeutics 237, 937-944 (1986).
Cushman et al Biochemistry 16, 5484 (1977) e.g. p. 5487.
Gruenfeld et al, j. med chem. 26, 1277 (1983).
Llorens et al, Biochem, Biophys, Res. Comm. 96, 1710-6 (1980).
Mumford et al, Biochem. Biophys. Research Comm. 109,1303 (1982).
Roques et al, Life Sciences 31 1749 (1982).
Fournie-Zaluski et al, Life Sciences 31 2947 (1982).

Affiliated with

Also associated with

Rating

N-substituted butyramide derivatives useful for treatment of con does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted butyramide derivatives useful for treatment of con, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted butyramide derivatives useful for treatment of con will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1891991